(Q38339519)

2 September 2017

1 reference

title

Somatostatin in portal hypertension (English)

1 reference

2 September 2017

Morgan JS

1

1 reference

2 September 2017

Groszmann RJ

series ordinal

2

1 reference

2 September 2017

publication date

1 March 1989

1 reference

Digestive Diseases and Sciences

2 September 2017

published in

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

3 Suppl

1 reference

2 September 2017

page(s)

40S-47S

1 reference

Effect of somatostatin on intestinal motility

2 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01536044

21 January 2018

1 reference

12 December 2020

Somatostatin suppresses secretin and pancreatic exocrine secretion

1 reference

12 December 2020

Proceedings: Effect of somatostatin on motilin levels and gastric emptying

1 reference

12 December 2020

Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin

1 reference

12 December 2020

The use of intravenous pituitrin in treatment of bleeding esophageal varices.

1 reference

12 December 2020

The use of vasopressin ('pitressin') in the control of bleeding from oesophageal varices

1 reference

12 December 2020

Circulatory effects of somatostatin in anesthetized man

1 reference

12 December 2020

Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus

1 reference

12 December 2020

Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.

1 reference

12 December 2020

A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage

1 reference

12 December 2020

SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENA

1 reference

12 December 2020

Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage

1 reference

12 December 2020

Efficacy of somatostatin and vasopressin in the control of acute variceal hemorrhage

1 reference

12 December 2020

Two types of somatostatin receptors differentiated by cyclic somatostatin analogs

1 reference

12 December 2020

Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension

1 reference

12 December 2020

Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat

1 reference

12 December 2020

Localization of somatostatin receptors

1 reference

12 December 2020

The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis

1 reference

12 December 2020

Treatment of Bleeding Esophageal Varices with Somatostatin

1 reference

12 December 2020

Somatostatin Not Helpful in Bleeding Esophageal Varices

1 reference

12 December 2020

A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices

1 reference

12 December 2020

Treatment of bleeding oesophageal varices with somatostatin

1 reference

12 December 2020

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

1 reference

12 December 2020

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

1 reference

12 December 2020

Inhibition of insulin secretion by somatostatin

1 reference

12 December 2020

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

1 reference

12 December 2020

Editorial: Somatostatin: newcomer from the hypothalamus

1 reference

12 December 2020

Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*

1 reference

12 December 2020

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

12 December 2020

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

12 December 2020

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

12 December 2020

Inhibition of growth hormone release in humans by somatostatin

1 reference

12 December 2020

Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats

1 reference

12 December 2020

Reduction in portal vein blood flow by somatostatin

1 reference

12 December 2020

Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis

1 reference

12 December 2020

Circulatory effects of somatostatin in anaesthetized dogs

1 reference

12 December 2020

Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus

1 reference

12 December 2020

Vasopressin effect on portal and systemic hemodynamics. Studies in intact, unanesthetized humans

1 reference

12 December 2020

Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial

1 reference

12 December 2020

Somatostatin decreases portal hypertension in the cirrhotic patient

1 reference

12 December 2020

Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.

1 reference

12 December 2020

Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects

1 reference

12 December 2020

Systemic and pulmonary haemodynamic effects of somatostatin

1 reference

12 December 2020

Effect of a Long-Acting Octapeptide Analogue of Somatostatin on Growth Hormone and Pancreatic and Gastrointestinal Hormones in Man

1 reference

12 December 2020

Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis

1 reference

12 December 2020

Human somatostatin I: sequence of the cDNA

1 reference

12 December 2020

Haemodynamic effects of somatostatin in acute gastrointestinal hemorrhage in dogs

1 reference

12 December 2020

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

12 December 2020

Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver

1 reference

12 December 2020

Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

1 reference

12 December 2020

Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly

1 reference

12 December 2020

Comparative Effect of Nitroglycerin and Nitroprusside on Vasopressin-Induced Cardiac Dysfunction in the Dog

1 reference

12 December 2020

Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus

1 reference

12 December 2020

Somatostatin bleeding esophageal varices: peer review, anyone?

1 reference

12 December 2020

Continuous intravenous vasopressin in active upper gastrointestinal bleeding

1 reference

12 December 2020

Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01536044

1 reference

Dimensions Publication ID

2 September 2017

1020462985

0 references

1 reference